Analysts have raised their price target for Mediobanca Banca di Credito Finanziario from €20.06 to €20.54. They cited improved revenue growth and slightly stronger profit margins as the primary drivers for the upward revision.
What's in the News
- Banca Monte dei Paschi called a board meeting to discuss potentially raising its $18 billion bid for Mediobanca and may add a cash component to the offer (Bloomberg).
- Approximately 13% of Mediobanca shares have been tendered to Banca Monte dei Paschi, marking a significant step in its takeover attempt (Bloomberg).
- Mediobanca CEO Alberto Nagel is set to resign after failing to block the takeover by Monte dei Paschi di Siena. This will end a 17-year tenure.
- Mediobanca will hold board meetings in September and November 2025 to approve financial statements for the respective quarters.
Valuation Changes
- Fair Value increased slightly from €20.06 to €20.54.
- Discount Rate has risen modestly from 11.05% to 11.14%.
- Revenue Growth improved from 7.25% to 8.11%.
- Net Profit Margin edged up from 39.46% to 39.88%.
- Future P/E declined from 13.94x to 12.79x, reflecting lower expected valuation multiples.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.